Sex hormones and the female voice

Journal of Voice

Volumn 13, Issue 3, 1999, Pages 424-446

  Abitbol, Jean ^a,b   Abitbol, Patrick ^b   Abitbol, Béatrice ^b  

^a Laboratoire de Psychologie   (France)

^b Hûpitaux de ParisnENT ^*  (France)

Author keywords

Female voice; Hormonal effects on voice; Menopausal vocal syndrome; Premenstrual vocal syndrome

Indexed keywords

ANTIINFLAMMATORY AGENT; ASCORBIC ACID; ESTROGEN; MAGNESIUM; MEFENAMIC ACID; MULTIVITAMIN; NICOTINAMIDE; PANTOTHENIC ACID; PROGESTERONE; PYRIDOXINE; SEX HORMONE; TESTOSTERONE; TROXERUTIN; VASOACTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DYSPHONIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; INFLAMMATORY DISEASE; LARYNGOGRAPHY; LARYNX DISORDER; LARYNX MUCOSA; LARYNX MUSCLE; MAJOR CLINICAL STUDY; MENOPAUSE; MUSCLE ATROPHY; PREMENOPAUSE; SPEECH REHABILITATION; VIBRATION; VOICE;

EID: 0032821590     PISSN: 08921997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-1997(99)80048-4     Document Type: Article

References (48)

1. Hemsell DL, Grodin JM, Brenner PF, Siiteri PKK, MacDonald PC. Plasma precursors of estrogens: II. Correlations of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab. 1974;38:476-479.
2. Sundberg J. The Science of the Singing Voice. Dekalb, III: Northern Illinois University Press; 1987.
3. Tarneaud J. Traité pratique de Phonologie et de Phoniatrie: La Voix, la Parole, le Chant. Paris, France: Librairie Maloine; 1941.
4. Abitbol J. La Voix au Féminin (Film de 22 min). 1997.
5. Abitbol J. Hormonal vocal cord cycle in women. J Voice. 1989;3:157-162.
6. Brodnitz F. Hormones and the human voice. Bull NY Acad Med. 1971;47:183-191.
7. Bardin CW, Brown TR, Isona VV, Janne OA. Progestins can mimic, inhibit and potentiate the actions of androgens. Pharmacol Ther. 1984;23:443-459.
8. Rozenbaum H. Les Progestatifs. Paris, France: Pariente Edicionnes; 1982.
9. Sataloff R. Genetics of the voice. In: Sataloff R, ed. Professional Voice: The Science and Art of Clinical Care. 2nd ed. Singular Publishing Group; 1997:89-92.
10. Damsté PH. Voice changes in adult women caused by virilizing agents. J Speech Hear Disord. 1967;32:126-132.
11. Abraham GE, Elsner CW, Lucas LA. Hormonal and behavioral changes during the menstrual cycle. Senologia. 1978;3:3.
12. De Kretser DM, Kerr JB. The cytology of the testis. In: Knobil E, Neill J, eds. The Physiology of Reproduction. Vol. 2. New York, NY: Raven Press; 1988:837-932.
13. MacDonald PC, Dombroski RA, Casey ML. Recurrent secretion of progesterone in large amounts: an endocrine/ metabolic disorder unique to young women? Endocr Rev. 1991;12:372-401.
14. Gates GA, Montalbo PJ. The effects of low dose beta blockade on performance anxiety in singers. J Voice. 1987;1:105-108.
15. Gramming P, Sundberg J, Ternstrom S, Leanderson R, Perkins W. Relationship between changes in voice pitch and loudness. J Voice, 1988;2:118-126.
16. Abitbol J, Atlas of Laser Voice Surgery. San Diego, Calif: Singular Publishing Group; 1995:221-249.
17. Endicott J, Halbreich U, Schacht S, Nee J. Premenstrual changes and affective disorders. Psychosomat Med. 1981; 43:519-529.
18. Mortola JF. The premenstrual syndrome. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive Endocrinology, Surgery, and Technology. Vol. 2. Philadelphia, Pa: Raven Press; 1996:1635-1647.
19. Mortota JF. Issues in the diagnosis and research of premen-strual syndrome. Clin Obstet Gynecol. 1992;35:587.
20. Mortola JF, Girton L, Beck L, Yen SSC. Diagnosis of premenstrual syndrome by simple prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990;76:302-307.
21. Montagnani CF, Arena B, Maffulli N. Estradiol and progesterone during exercise in healthy women. Med Sci Sports Exerc. 1992;24:764-768.
22. Meisfelt RL. The structure and function of steroid receptor proteins. Crit Rev Biochem Molec Biol. 1989;24:101-117.
23. Munday MR, Brush MG, Taylor RW. Progesterone, aldosterone levels in premenstrual syndrome. J Endocrinol. 1977; 73:21P-22P.
24. Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by use of gonadotrophin-releasing hormone agonist and progestin. J Clin Endocrinol Metab. 1991;71:252A-252F.
25. Abitbol J. Vocal cord hemorrhages in voice professionals. J Voice. 1988;1:261-266.
26. Casper RF, Patel-Christopher N, Powell AM. Thyrotropin and prolactin responses to thyrotropin releasing hormone in premenstrual syndrome. J Clin Endocrinol Metab. 1989; 68:608-612.
27. Abitbol J. Voix de Femmes (Film de 27 min). 1996.
28. Adashi EY. The climateric ovary: an androgen-producing gland. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive Endocrinology, Surgery, and Technology. Vol. 2. Philadelphia, Pa: Raven Press; 1996:1745-1757.
29. Applegarth LD. Emotional implications. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive Endocrinology, Surgery, and Technology. Vol. 2. Philadelphia, Pa: Raven Press; 1995:1953-1968.
30. Chang RJ, Judd HL. The ovary after menopause. Clin Obstet Gynecol. 1981;24:181.
31. Chodzko-Zajko WJ, Ringer RL. Physiological aspects of aging. J Voice. 1987;1:18-26.
32. Fedor-Feyberg P. The influence of estrogens on the well-being and mental performances in climateric and post-menopausal women. Acta Obstet Gynecol Scand. 1979;64:1-6.
33. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973;36:207-214.
34. Buchsbaum HJ. The Menopause. New-York, NY: Springer-Verlag; 1987.
35. Hutton JD, Jacobs HS, James VHT. Steroid endocrinology after the menopause: a review. JR Soc Med. 1979;72:85.
36. McAllister JM, Kerin JFP, Trant JM, Estabrook RW, Mason JL, Waterman MR, Simpson ER. Regulation of cholesterol side chain cleavage and 17 α-Hydroxylase/lyse in proliferating human theca interna cells in long-term monolayer culture. Endocrinology. 1989;125:1959-1966.
37. Christiansen C. Menopausal osteoporosis: impact of sex steroid replacement. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive Endocrinology, Surgery, and Technology. Vol. 2. Philadelphia, Pa: Raven Press; 1995:1825-1839.
38. Filicori M, Butler JP, Crowley WF. Neuroendocrine regulation of the corpus tuteum in the human. J Clin Invest. 1984; 73:1968-1647.
39. Naftolin F, Ryan KJ, Davies LI, et al. The formation of estrogens by central neuroendocrine tissue. Recent Prog Honn Res. 1975:31:295-319.
40. Histoire des Castrats. Paris, France: Editeur Grasset; 1989.
41. Harada N. A unique aromatas (P450arom) MRNA formed by alternative use of tissue specific exons I in human skin fibroblasts. Biochem Biophys Res Commun. 1992;189:1001-1007.
42. Inkster SE, Brodie AMH. Expression of aromatose cytochrome P-450 in premenopal and postmenopausal human ovaries and immunocytochemical study. J Clin Endocrinol Metab. 1991;73:717.
43. Sasano H, Okamoto M, Mason JL, et al. Immunolocalization of aromataze, 17α-Hydroxylase and side-chain-cleavage P-450 in the human ovary. J Reprod Fertil. 1989;85:163-169.
44. Ting Zhao JE, Nichols SE, Buln SE, Mendelson CR, Simpson ER. Aromatase P450 gene expression in human adipose tissue. J Biol Chem. 1995;270:16449-16457.
45. Edman CD, MacDonald PC. The role of extraglandular estrogens in women in health and disease. In: James VHT, Serio M, Giusti G, eds. The Endocrine Function of the Human Ovary. New-York, NY: Academic Press; 1976:135-140.
46. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab. 1983;57:304-310.
47. Hauner H, Schmid P, Pfeiffer EF. Glucocorticoids and insulin promote the differenciation fo human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab. 1987; 64:832-835.
48. Nagamani M, Hannigan EV, Dinh VT, Stuart CA. Hyperin-sulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer. J Clin Endocrinol Metab. 1988;67:144.